Clinical Trial Update: Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of durvalumab and tremelimumab with best supportive care versus best supportive care in advanced colorectal cancer has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-01-19